Cellosaurus OV90D-6 (CVCL_4Z25)

Cell line name OV90D-6
Accession CVCL_4Z25
Resource Identification Initiative To cite this cell line use: OV90D-6 (RRID:CVCL_4Z25)
Comments Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
Omics: Transcriptome analysis.
Disease Ovarian adenocarcinoma (NCIt: C7700)
Derived from metastatic site: Ascites.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_3768 (OV-90)
Sex of cell Female
Category Cancer cell line
Publications

PubMed=22141344; DOI=10.1186/1757-2215-4-21
Sherman-Baust C.A., Becker K.G., Wood W.H. III, Zhang Y., Morin P.J.
Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin.
J. Ovarian Res. 4:21-21(2011)